the iron removed at each phlebotomy session averaged 49.1 +/- 2.0 mg , similar to the amount of iron removed with deferoxamine administration in patients undergoing dialysis who had iron overload , but without the potential for adverse side effects reported with long-term deferoxamine therapy .
C0282193
iron overload
C0011145
deferoxamine